Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model

被引:279
作者
Dobrowolny, G
Giacinti, C
Pelosi, L
Nicoletti, C
Winn, N
Barberi, L
Molinaro, M
Rosenthal, N
Musarò, A
机构
[1] Univ Roma La Sapienza, CE BEMM, Dept Histol & Med Embryol, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Interuniv Inst Mycol, I-00161 Rome, Italy
[3] EMBL Mouse Biol Program, I-00016 Monterotondo, Italy
[4] Edith Cowan Univ, Churchlands, WA 6027, Australia
关键词
D O I
10.1083/jcb.200407021
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by a selective degeneration of motor neurons, atrophy, and paralysis of skeletal muscle. Although a significant proportion of familial ALS results from a toxic gain of function associated with dominant SOD1 mutations, the etiology of the disease and its specific cellular origins have remained difficult to define. Here, we show that muscle-restricted expression of a localized insulin-like growth factor (Igf) -1 isoform maintained muscle integrity and enhanced satellite cell activity in SOD1(G93A) transgenic mice, inducing calcineurin-mediated regenerative pathways. Muscle-specific expression of local Igf-1 (mIgf-1) isoform also stabilized neuromuscular junctions, reduced inflammation in the spinal cord, and enhanced motor neuronal survival in SOD1(G93A) mice, delaying the onset and progression of the disease. These studies establish skeletal muscle as a primary target for the dominant action of inherited SOD1 mutation and suggest that muscle fibers provide appropriate factors, such as mIgf-1, for neuron survival.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 21 条
  • [11] 2-#
  • [12] Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model
    Kaspar, BK
    Lladó, J
    Sherkat, N
    Rothstein, JD
    Gage, FH
    [J]. SCIENCE, 2003, 301 (5634) : 839 - 842
  • [13] Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease
    Lino, MM
    Schneider, C
    Caroni, P
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (12) : 4825 - 4832
  • [14] Diseases of the neuromuscular junction
    McConville, J
    Vincent, A
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (03) : 296 - 301
  • [15] Musarò A, 1999, MOL CELL BIOL, V19, P3115
  • [16] Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1
    Musarò, A
    Giacinti, C
    Borsellino, G
    Dobrowolny, G
    Pelosi, L
    Cairns, L
    Ottolenghi, S
    Cossu, G
    Bernardi, G
    Battistini, L
    Molinaro, M
    Rosenthal, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (05) : 1206 - 1210
  • [17] Musaro A., 2002, Current Genomics, V3, P149, DOI 10.2174/1389202023350462
  • [18] IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1
    Musarò, A
    McCullagh, KJA
    Naya, FJ
    Olson, EN
    Rosenthal, N
    [J]. NATURE, 1999, 400 (6744) : 581 - 585
  • [19] Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle
    Musarò, A
    McCullagh, K
    Paul, A
    Houghton, L
    Dobrowolny, G
    Molinaro, M
    Barton, ER
    Sweeney, HL
    Rosenthal, N
    [J]. NATURE GENETICS, 2001, 27 (02) : 195 - 200
  • [20] Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
    Rothstein, JD
    DykesHoberg, M
    Pardo, CA
    Bristol, LA
    Jin, L
    Kuncl, RW
    Kanai, Y
    Hediger, MA
    Wang, YF
    Schielke, JP
    Welty, DF
    [J]. NEURON, 1996, 16 (03) : 675 - 686